Skip to main content
. 2021 Oct 26;36(7):591–603. doi: 10.1038/s41371-021-00612-6

Table 7.

Ongoing challenges in existing hypertension programs and corresponding solutions.

Step Challenge Solution
1→ Establishing administrative structure • Transitioning from donor-funded program to government-owned program.

• Jointly implement program with ministry of health from program start.

• Develop a transition plan that considers roles, responsibilities, and budgeting for products and services long-term.

2 → Treatment protocols • Converging on a universal treatment protocol. • Build evidence for treatment protocols through demonstration programs.
3→ Medications and BP devices

• Medication stock-outs

• Limited uptake of fixed dose combination medications.

• Variable medication quality and affordability

• Lack of availability of validated BP devices.

• Poor awareness among providers and program managers of the importance of BP device validation.

• High cost of BP devices.

• Market shaping to reduce prices of fixed dose combination antihypertensive medications.

• Strengthen procurement and supply chains in LMICs.

• Build capacity of ministry of health staff to forecast medication supply needs.

• Advocate for reduced out-of-pocket medication fees for patients

• Advocate for coverage of NCD medications and services under national health insurance schemes.

4→ Training of health care workers and supervision

• Learnings from training not being implemented or sustained.

• Need for frequent trainings due to frequent turnover of staff.

• Assess the impact of training and areas for improvement.

• Conduct refresher training.

• Provide ongoing clinical mentorship.

• Expand training to include community health workers, patient champions, and community-based providers.

5→ Information systems

• Lack of electronic health records

• Limited use of data for program improvement.

• Government investment in electronic health records.

• Build capacity for continuous quality improvement utilizing program data.

• Include key hypertension control indicators in program reviews at national/subnational levels.

6→ Enroll patients and pilot

• Transitioning from pilot projects to scale-up.

• Lack of human resources for scale-up.

• Scale-up team-based care through capacity building of existing health care workers and training new cadres of health care workers.

• Roll-out packages of differentiated service delivery specific to location context.

• Government investment in hypertension care.